the emerging continuum of care in metastatic kidney cancer in the second-line and beyond
Published 2 years ago • 206 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
5:57
current landscape and future direction in systemic therapy for renal cell carcinoma (rcc)
-
4:15
the unmet needs of kidney cancer treatment
-
1:09
advancements in systemic therapy for kidney cancer: implications for treatment decision-making
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
5:11
current treatment landscape for kidney cancer
-
38:59
new and emerging systemic treatment options for metastatic kidney cancer scott s. tykodi, m.d., phd.
-
1:42
current treatment landscape in renal cell carcinoma
-
11:56
axitinib is the new standard of care in 2nd-line: pro brian i. rini, m.d.
-
23:55
what novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
1:48
what is the best second-line treatment of advanced renal cell carcinoma (rcc)?
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
27:47
what is the best front line treatment for metastatic clear cell rcc in 2018?
-
0:59
updates in kidney cancer at esmo 2022
-
1:42:57
live webinar on management of renal cell carcinoma in the new millennium
-
5:16
potential new treatments in renal cell carcinoma
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
7:05
upfront immunotherapy for metastatic kidney cancer